Sleep Disorder (Healthy Volunteers) Clinical Trial
Official title:
An Open Label, Single Arm, Exploratory Study to Estimate the Range of Improvement of the Quality of Sleep With NOVANUIT® Triple Action in Subjects With Mild to Moderate Sleep Disorders
Primary Objective: To estimate the range of improvement of NOVANUIT® triple action on sleep quality global score. Secondary Objectives: - To estimate the range of improvement of NOVANUIT® triple action on following parameters: time for getting asleep, sleep time, number of nocturnal awakening, number of nightmares, sleep quality (score from 0 to 10), and mean tiredness during the day (score from 0 to 10). - To estimate persistency of NOVANUIT® triple action effects after end of study product consumption. - To assess dependency to NOVANUIT® triple action after study product cessation. - To assess tolerance of NOVANUIT® triple action during the study.
Study participation duration for each participant will be 4 weeks including a 2-week treatment period. ;